Adrian Gervais
Inserm(FR)Inserm(FR)Université Paris Cité(FR)Institut Necker Enfants Malades(FR)Sorbonne Paris Cité(FR)Pediatrics and Genetics(US)Human Genetic of Infectious Diseases(FR)Institut des Maladies Génétiques Imagine(FR)Rockefeller University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunodeficiency and Autoimmune Disorders, Diabetes and associated disorders, interferon and immune responses
Most-Cited Works
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19(2021)415 cited
- → Human genetic and immunological determinants of critical COVID-19 pneumonia(2022)384 cited
- → Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1(2021)300 cited
- → Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19(2021)233 cited
- → Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine(2021)228 cited